Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis
Response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C due to genotype 4
A continuous 13C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT
Where are people being tested for anti-HCV in England? Results from sentinel laboratory surveillance
Microsomal triglyceride transfer protein (MTP) –493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients
Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients
Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease
Human dendritic cells pulsed with specific lipopeptides stimulate autologous antigen-specific T cells without the addition of exogenous maturation factors